Christiane E Angermann Selected Research

Christiane E Angermann Research Topics

Disease

53	Heart Failure 04/2024 - 03/2003
7	Cardiomyopathies (Cardiomyopathy) 04/2024 - 10/2006
5	Systolic Heart Failure 01/2017 - 04/2007
4	Heart Diseases (Heart Disease) 07/2010 - 03/2004
3	Inflammation (Inflammations) 12/2009 - 03/2004
2	Fatigue 04/2019 - 06/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2012 - 02/2012
2	Chronic Disease (Chronic Diseases) 06/2011 - 01/2006
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2007 - 03/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2005 - 09/2003
2	Myocardial Infarction 07/2004 - 03/2003
2	Cardiomegaly (Heart Hypertrophy) 03/2004 - 09/2003
1	Weight Loss (Weight Reduction) 01/2023
1	Pulmonary Hypertension 12/2022
1	Acute Kidney Injury (Acute Renal Failure) 10/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Ischemia 01/2020
1	Atrial Fibrillation 04/2019
1	Neoplasms (Cancer) 01/2019
1	Mood Disorders (Mood Disorder) 12/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2018
1	Body Weight (Weight, Body) 06/2017
1	Death (Near-Death Experience) 01/2017
1	Muscle Weakness 06/2011
1	Edema (Dropsy) 02/2011
1	Hyperuricemia 02/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2011
1	Essential Hypertension 12/2009
1	Fibrosis (Cirrhosis) 12/2009
1	Immunoglobulin Light-chain Amyloidosis 03/2008
1	Amyloidosis 03/2008
1	Pathologic Constriction (Stenosis) 06/2007
1	Hypercholesterolemia 04/2007

Drug/Important Bio-Agent (IBA)

7	empagliflozinIBA 04/2024 - 01/2022
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2009
4	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2022
4	AutoantibodiesIBA 10/2023 - 10/2006
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 04/2007
4	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2022 - 01/2021
4	Natriuretic PeptidesIBA 06/2017 - 09/2004
3	DiureticsIBA 01/2023 - 02/2011
3	SodiumIBA 01/2021 - 04/2007
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 04/2007
2	Mineralocorticoid Receptor AntagonistsIBA 10/2023 - 04/2015
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023 - 01/2022
2	pro-brain natriuretic peptide (1-76)IBA 04/2019 - 09/2004
2	Bromocriptine (Parlodel)FDA LinkGeneric 09/2017 - 11/2015
2	ProlactinIBA 09/2017 - 11/2015
2	Escitalopram FDA Link 10/2016 - 06/2016
2	Serotonin (5 Hydroxytryptamine)IBA 06/2016 - 12/2007
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015 - 02/2011
2	Angiotensin Receptor AntagonistsIBA 04/2015 - 02/2011
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2015 - 04/2007
2	AldosteroneIBA 03/2015 - 04/2007
2	GoldIBA 08/2012 - 02/2012
2	Bronchodilator Agents (Bronchodilators)IBA 08/2012 - 02/2012
2	CholesterolIBA 02/2011 - 11/2009
2	NF-kappa B (NF-kB)IBA 09/2004 - 03/2003
2	p38 Mitogen-Activated Protein KinasesIBA 07/2004 - 09/2003
2	Proteins (Proteins, Gene)FDA Link 07/2004 - 03/2003
1	Furosemide (Lasix)FDA LinkGeneric 01/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	AntigensIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	SymportersIBA 01/2021
1	CreatinineIBA 01/2020
1	Uric Acid (Urate)IBA 04/2019
1	hydroxide ionIBA 04/2019
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019
1	LipidsIBA 01/2019
1	Docosahexaenoic AcidsIBA 01/2019
1	Eicosapentaenoic AcidIBA 01/2019
1	Troponin IIBA 04/2017
1	NeuropeptidesIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	AdrenomedullinIBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 08/2016
1	AndrogensIBA 06/2011
1	Testosterone (Sustanon)FDA Link 06/2011
1	Procollagen Type IIBA 12/2009
1	procollagen Type III-N-terminal peptide (PIIP)IBA 12/2009
1	CollagenIBA 12/2009
1	Collagen Type I (Type I Collagen)IBA 12/2009
1	Collagen Type III (Type III Collagen)IBA 12/2009
1	Amyloid (Amyloid Fibrils)IBA 03/2008
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 03/2008
1	Prealbumin (Transthyretin)IBA 03/2008
1	ImmunosorbentsIBA 07/2007
1	EnzymesIBA 07/2007
1	AntibodiesIBA 07/2007
1	Adenosine Monophosphate (AMP)IBA 07/2007
1	Adenosine (Adenocard)FDA LinkGeneric 06/2007

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2006
9	Drug Therapy (Chemotherapy) 12/2023 - 09/2004
4	Patient Readmission 01/2023 - 09/2004
4	Micro-Electrical-Mechanical Systems 12/2022 - 11/2018
1	Length of Stay 10/2023
1	Ambulatory Care (Outpatient Care) 12/2019
1	Cognitive Training 08/2016
1	Heart Transplantation (Grafting, Heart) 11/2015